These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29397905)

  • 41. Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.
    Peacock JW; Nordone SK; Jackson SS; Liao HX; Letvin NL; Yafal AG; Gritz L; Mazzara GP; Haynes BF; Staats HF
    J Virol; 2004 Dec; 78(23):13163-72. PubMed ID: 15542668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys.
    Gil L; Izquierdo A; Lazo L; Valdés I; Ambala P; Ochola L; Marcos E; Suzarte E; Kariuki T; Guzmán G; Guillén G; Hermida L
    Virology; 2014 May; 456-457():70-6. PubMed ID: 24889226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.
    Khera AK; Afkhami S; Lai R; Jeyanathan M; Zganiacz A; Mandur T; Hammill J; Damjanovic D; Xing Z
    J Immunol; 2015 Sep; 195(6):2900-7. PubMed ID: 26268652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.
    Kurane I; Innis BL; Nisalak A; Hoke C; Nimmannitya S; Meager A; Ennis FA
    J Clin Invest; 1989 Feb; 83(2):506-13. PubMed ID: 2521489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted Delivery of VP1 Antigen of Foot-and-mouth Disease Virus to M Cells Enhances the Antigen-specific Systemic and Mucosal Immune Response.
    Kim SH; Lee HY; Jang YS
    Immune Netw; 2013 Aug; 13(4):157-62. PubMed ID: 24009543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.
    Liu WT; Lin WT; Tsai CC; Chuang CC; Liao CL; Lin HC; Hung YW; Huang SS; Liang CC; Hsu HL; Wang HJ; Liu YT
    Vaccine; 2006 Jul; 24(31-32):5852-61. PubMed ID: 16759760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
    Ye M; Morello CS; Spector DH
    J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
    Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
    Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
    Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
    Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vaginal type-II mucosa is an inductive site for primary CD8⁺ T-cell mucosal immunity.
    Wang Y; Sui Y; Kato S; Hogg AE; Steel JC; Morris JC; Berzofsky JA
    Nat Commun; 2015 Jan; 6():6100. PubMed ID: 25600442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Microfold cells-targeting antigen delivery: a promising strategy to enhance the efficacy of mucosal vaccines].
    Wang Y; Li M; Sun Y; Qiu HJ
    Sheng Wu Gong Cheng Xue Bao; 2019 Feb; 35(2):216-225. PubMed ID: 30806051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient generation of mucosal and systemic antigen-specific CD8+ T-cell responses following pulmonary DNA immunization.
    Bivas-Benita M; Bar L; Gillard GO; Kaufman DR; Simmons NL; Hovav AH; Letvin NL
    J Virol; 2010 Jun; 84(11):5764-74. PubMed ID: 20335249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. M cell-targeting ligand and consensus dengue virus envelope protein domain III fusion protein production in transgenic rice calli.
    Kim TG; Kim MY; Huy NX; Kim SH; Yang MS
    Mol Biotechnol; 2013 Jul; 54(3):880-7. PubMed ID: 23250723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucosal Immune System and M Cell-targeting Strategies for Oral Mucosal Vaccination.
    Kim SH; Lee KY; Jang YS
    Immune Netw; 2012 Oct; 12(5):165-75. PubMed ID: 23213309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The development of mucosal vaccine using bacterial function for targeting mucosal tissues].
    Suzuki H; Kondoh M; Yagi K; Kiyono H; Kunisawa J
    Yakugaku Zasshi; 2014; 134(5):629-34. PubMed ID: 24790045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of B cells by a dendritic cell-targeted oral vaccine.
    Sahay B; Owen JL; Yang T; Zadeh M; Lightfoot YL; Ge JW; Mohamadzadeh M
    Curr Pharm Biotechnol; 2013; 14(10):867-77. PubMed ID: 24372255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.